openPR Logo
Press release

Global Pharmaceutical Pellets Market Projected to Grow at 11.8% CAGR, Reaching $3.16 Billion by 2029

07-11-2025 06:09 PM CET | Health & Medicine

Press release from: The Business Research Company

Pharmaceutical Pellets Market

Pharmaceutical Pellets Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Pharmaceutical Pellets Industry Market Size Be by 2025?
The scale of the pharmaceutical pellets market has expanded swiftly over recent years. The market is projected to increase from $1.82 billion in 2024 to $2.03 billion in 2025, witnessing a compound annual growth rate (CAGR) of 11.0%. The growth observed during the historic period is credited to factors such as increased oral dosage forms, improved patient compliance, initiatives in pharmaceutical research, efforts towards taste-masking and stability enhancement, and regulatory approvals and patents.

What's the Long-Term Growth Forecast for the Pharmaceutical Pellets Market Size Through 2029?
In the foreseeable future, the pharmaceutical pellets market is projected to experience a swift expansion. The market is set to reach a value of $3.16 billion by 2029, registering a compound annual growth rate (CAGR) of 11.8%. Factors contributing to this growth during the forecast period include the burgeoning demand for pediatric dosage forms, multi-particulate dosage forms, and advancements in the development of combination therapy dosage forms. Other factors include continuous manufacturing progress and a heightened focus on geriatric dosage forms. Key trends predicted to stir the market during this period include the integration of 3D printing technologies, their application in personalized nutrition, the development of smart coatings for real-time monitoring, orally disintegrating pellets, and biodegradable and eco-friendly pellets.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-pellets-global-market-report

What Are the Key Growth Drivers Fueling the Pharmaceutical Pellets Market Expansion?
The pharmaceutical pellets market is expected to expand due to the escalating occurrence of chronic diseases. Usually, these diseases persist for a year or more, necessitate continuous medical attention and can limit ordinary activities. Implementing pharmaceutical pellets in the treatment of chronic illnesses can be advantageous as they reduce gastrointestinal issues and augment drug absorption. As cited by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, in January 2023, by 2050, there will be a 99.5% increase in individuals aged 50 and above suffering from at least one chronic disease, shooting up from 71.522 million in 2020 to 142.66 million. Hence, the rising incidence of chronic diseases is fueling the growth of the pharmaceutical pellets market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12354&type=smp

What Are the Key Trends Driving Pharmaceutical Pellets Market Growth?
The pharmaceutical pellets market is seeing an increasing trend in product innovation. Pharmaceutical pellets companies are innovating new products to maintain their market standing. For example, in May 2024, the US-based engineering firm, Schedio SA, introduced the High Potent Pilot Particle Engineering Platform. This sophisticated platform can accommodate up to 465 configurations and is compatible with jet mills and spray dryers, aiming to improve particle engineering for high-potency drugs in the pharmaceutical sector. It comes with high containment and easy-to-use controls, meant to guarantee precision, safety, and compliance with regulations in the manufacturing processes of pharmaceuticals.

How Is the Pharmaceutical Pellets Market Segmented?
The pharmaceutical pellets market covered in this report is segmented -

1) By Technology: Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution And Suspension Layering, Spray Congealing, Spray Drying
2) By Mechanism Of Action: Diffusion, Erosion, Osmosis
3) By Technique: Direct, Melt, Wet, Dry
4) By End-User: Pharmaceutical, Nutraceutical

Subsegments:
1) By Extrusion: Melt Extrusion, Solvent-Based Extrusion
2) By Fluid Bed Granulation: Top-Spray Granulation, Bottom-Spray Granulation
3) By Dry Powder Layering: Powder Layering On Inert Cores, Coating Techniques
4) By Solution And Suspension Layering: Solution Layering, Suspension Layering
5) By Spray Congealing: Hot Melt Spraying, Cooling Methods
6) By Spray Drying: Single-Stage Spray Drying, Multi-Stage Spray Drying

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12354&type=smp

Which Companies Are Leading the Charge in Pharmaceutical Pellets Market Innovation?
Major companies operating in the pharmaceutical pellets market include Abbott Laboratories, Takeda, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Colorcon Inc., Nordic Sugar AB, Pfizer, Merck & Co., Manus Aktteva Biopharma LLP, Thexa Pharma (P) Limited, Avanscure Lifesciences Private Limited, MB Sugars & Pharmaceuticals Limited, CIL Laboratories Pvt Ltd, Sainor Pharma Pvt Ltd, Umang Pharmatech Pvt Ltd, Nami Lifesciences Pvt Ltd, Lograns Pharma Private Limited, Rainbow Health Care Products, Chemit Laboratories, Concord Drugs Limited, Pharmaceuticals Private Limited, Nanjing Joyfulchem ​​Co. Ltd., Praful International Corporation, Pellets Pharma Limited, A B Enterprises, Vision Pharmacoat Pvt Ltd, Spansules Pharma, Ravoos Laboratories Ltd

Which Regions Are Leading the Global Pharmaceutical Pellets Market in Revenue?
North America was the largest region in the pharmaceutical pellets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical pellets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12354

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pharmaceutical Pellets Market Projected to Grow at 11.8% CAGR, Reaching $3.16 Billion by 2029 here

News-ID: 4101516 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the